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P-values of statistical significant findings Figure S1 . Effect of liraglutide and RM-493 co-treatment on body weight and body composition in DIO mice. (A-C) Five-day treatment and (D-F) 22-day treatment of DIO male mice with vehicle (white), liraglutide (10 nmoles/kg) (grey), RM-493 (3.6 μmoles/kg) (black) or liraglutide (10 nmoles/kg) and RM-493 (3.6 μmoles/kg) (checkered). Effects on (A) body weight and (B and C) body composition following 5 days of treatment. Effects on (D) body weight and (E and F) body composition following 22 days of treatment. Compounds were administered by daily subcutaneous injections. Data represent means ± SEM; n = 8; *P < 0.05, **P < 0,01, ***P < 0.001. 
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